296. 胆道閉鎖症 Biliary atresia Clinical trials / Disease details
臨床試験数 : 63 / 薬物数 : 65 - (DrugBank : 37) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 63
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04494763 (ClinicalTrials.gov) | August 15, 2020 | 19/4/2018 | Primary Prophylaxis for Variceal Bleed in Biliary Atresia | Propanolol for Primary Prophylaxis for Variceal Bleed in Biliary Atresia - An Open Label Randomized Controlled Study | Portal Hypertension, Biliary Atresia | Drug: Propanolol;Other: Placebo | Institute of Liver and Biliary Sciences, India | NULL | Recruiting | 6 Months | 5 Years | All | 92 | N/A | India |